StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) shareholders

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Ownership

Who owns Pure Bioscience's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jeffrey Scott KitchellPresident, Corporate Secretary12,9980.01%Nov 28, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Robert F. Bartlett
CEO, Director
Mar 22, 2023Buy+50,000$0.16$8.00K50,000
Bernard Blotner
Director
Mar 21, 2023Buy+10,000$0.13$1.30K10,000
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Dec 15, 2022Buy+50,000$0.13$6.50K5,001,843
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Jul 15, 2022Award+15,741,666$0.15$2.36M29,143,617
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Jul 15, 2022Award+6,000,000$0.15$900.00K6,000,000
David Rendall
Director
Jul 15, 2022Award+325,000$0.15$48.75K402,371
Ivan Chen
Director
Jul 15, 2022Award+300,000$0.15$45.00K750,000
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Mar 21, 2022Buy+185,000$0.20$37.00K4,951,843
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Mar 17, 2022Buy+13,250$0.18$2.39K4,766,843
Tom Y. Lee
Chief Executive Officer, Director, 10% owner
Mar 16, 2022Buy+21,227$0.18$3.82K4,753,593
Tom Y. Lee
Chief Executive Officer, Director
Jun 16, 2021Buy+35,998$0.43$15.48K4,732,366
Tom Y. Lee
Chief Executive Officer, Director
Dec 24, 2020Buy+851$0.65$5534,696,368
Tom Y. Lee
Chief Executive Officer, Director
Dec 22, 2020Buy+45,299$0.66$29.90K4,695,517
Tom Y. Lee
Chief Executive Officer, Director
Dec 21, 2020Buy+7,859$0.68$5.34K4,650,218
Dale Okuno
Director
Dec 19, 2020Sale−748,880$0.29$217.18K5,560,540
Tom Y. Lee
Chief Executive Officer, Director
Dec 17, 2020Buy+4,712$0.65$3.06K4,642,359
Tom Y. Lee
Chief Executive Officer, Director
Dec 16, 2020Buy+20,000$0.67$13.40K4,637,647
Tom Y. Lee
Chief Executive Officer, Director
Jun 24, 2020Other−10,732,222––13,401,951
Tom Y. Lee
Chief Executive Officer, Director
Jun 22, 2020Buy+13,124$1.72$22.57K4,617,647
Tom Y. Lee
Chief Executive Officer, Director
Jun 19, 2020Buy+10,000$1.85$18.50K4,604,523
Tom Y. Lee
Chief Executive Officer, Director
Jun 18, 2020Buy+30,000$1.75$52.50K4,594,523
Tom Y. Lee
Chief Executive Officer, Director
Jun 17, 2020Buy+26,876$1.61$43.27K4,564,523
Tom Y. Lee
Chief Executive Officer, Director
Jun 16, 2020Buy+70,000$1.62$113.40K4,537,647
Tom Y. Lee
Chief Executive Officer, Director
Jun 15, 2020Buy+60,000$1.82$109.20K4,467,647
Tom Y. Lee
Chief Executive Officer, Director
Jun 12, 2020Buy+45,157$1.91$86.25K4,407,647
Thomas Richard Myers
Chief Operating Officer
May 1, 2020Award+500,000––587,500
Dale Okuno
Director
Mar 9, 2020Award+1,551,724$0.29$450.00K7,072,264
Tom Y. Lee
Director
Mar 9, 2020Award+2,243,103$0.29$650.50K24,134,173
Ivan Chen
Director
Mar 9, 2020Award+179,311$0.29$52.00K450,000
Tom Y. Lee
Director
Feb 14, 2020Gift−1,000,000––21,891,070
Tom Y. Lee
Director
Feb 14, 2020Gift+1,000,000––1,000,000
Dale Okuno
Director
Dec 31, 2019Sale−40,000$0.28$11.20K5,520,540
Tom Y. Lee
Director
Dec 19, 2019Buy+754,884$0.29$218.92K22,891,070
Tom Y. Lee
Director
Oct 2, 2019Award+1,000,000$0.29$290.00K22,136,186
Dale Okuno
Director
Oct 2, 2019Award+862,068$0.29$250.00K6,309,420
Dale Okuno
Director
Oct 2, 2019Buy+862,068$0.29$250.00K6,309,420
Tom Y. Lee
Director
Oct 2, 2019Buy+1,000,000$0.29$290.00K22,136,186
Tom Y. Lee
Director
Jul 2, 2019Gift+1,000,000––1,000,000
Tom Y. Lee
Director
Jul 2, 2019Gift−1,000,000––21,136,186
Tom Y. Lee
Director
Jul 1, 2019Gift+1,000,000––1,000,000
Tom Y. Lee
Director
Jul 1, 2019Gift−1,000,000––22,136,186
Ivan Chen
Director
May 9, 2019Buy+120,689$0.29$35.00K270,689
Dale Okuno
Director
May 9, 2019Buy+862,068$0.29$250.00K5,447,352
Dale Okuno
Director
May 9, 2019Buy+714,285$0.35$250.00K5,299,569
Ivan Chen
Director
May 9, 2019Buy+100,000$0.35$35.00K250,000
Dale Okuno
Director
Feb 19, 2019Option exercise+213,333$0.35$74.67K4,585,284
Tom Y. Lee
Director
Feb 19, 2019Option exercise+2,133,333$0.35$746.67K23,136,186
Tom Y. Lee
Director
Aug 16, 2018Buy+2,336,187$0.45$1.05M21,002,853
Henry R. Lambert
Chief Executive Officer, Director
Aug 13, 2018Award+200,000––698,056
Ivan Chen
Director
Jun 28, 2018Award+150,000––150,000
Henry R. Lambert
Chief Executive Officer, Director
Jan 12, 2018Sale−677$0.93$630518,379
Henry R. Lambert
Chief Executive Officer, Director
Jan 12, 2018Sale−9,000$0.94$8.46K509,379
Henry R. Lambert
Chief Executive Officer, Director
Jan 12, 2018Sale−11,323$0.90$10.19K498,056
Henry R. Lambert
Chief Executive Officer, Director
Jan 11, 2018Sale−2,000$0.94$1.88K519,056
Henry R. Lambert
Chief Executive Officer, Director
Jan 10, 2018Sale−18,500$0.94$17.39K521,056
Tom Y. Lee
Director
Dec 29, 2017Buy+18,666,666––18,666,666
Franchise Brands, LLC
10% owner
Dec 29, 2017Sale−18,666,666––0
Elisabeth Hagen
Director
Nov 2, 2017Award+150,000––150,000
Tom Y. Lee
Director
Sep 25, 2017Option exercise+208,038$0.40$83.22K4,362,490
William Otis
Director
Sep 25, 2017Option exercise+9,066$0.60$5.44K181,732

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-54.8%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pure Bioscience's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?